Hyper-converged Infrastructure Market Industry Analysis Comparing Industry Prospects And Challenges Of Investing

The global hyper-converged infrastructure market is estimated to reach USD 13.96 billion by 2024, according to a report by Grand View Research, Inc. Hyper-converged infrastructure is a software-based architecture that integrates storage, compute, virtualization, and networking resources in a box. The HCI systems are supported by a single vendor. They eliminate the need for making individual purchases of servers and virtualization software running on those servers and management tools, and do not require the installation of Storage-area Network (SAN) or Network-attached Storage (NAS). This integration, in turn, reduces the overall cost of the hyper-converged infrastructure system. The HCI market is still in its introductory stage and the adoption of Virtual Desktop Infrastructure (VDI) is anticipated to boost the industry growth over the next seven years.

The industry is expected to witness tremendous growth, owing to the increasing demand to enhance IT operational efficiency, reduce IT costs, and improve data protection. The demand for HCI is expected to increase in various verticals, such as BFSI, IT & telecom, healthcare, and government sectors, among others, considering its advantages over the traditional converged infrastructure.

The HCI market in North America is anticipated to show promising growth opportunities in the coming years due to the presence of a wide number of players across the U.S., such as Nutanix, Inc. (U.S.), Pivot3 (U.S.), Scale Computing, Inc. (U.S.), SimpliVity Corporation (U.S.), and VMware, Inc. (U.S.), among others. These market players offer HCI solutions majorly across the financial sector, government organizations, and IT & telecom, which forms the major segment of the overall hyper-converged infrastructure market. Moreover, in the recent months, about 40% large and 35% mid-tier organizations intend to shift from the traditional architecture to the hyper-converged infrastructure to attain simplicity of operations and cost savings.

Hyper-converged infrastructure is extensively used in the mid and large size enterprises for virtual desktop infrastructure projects, largely due to their ability to eradicate the complexity during implementation and issues regarding SAN-based storage solutions. It also reduces the overall cost in comparison with the traditional converged architecture. Different workloads run on these solutions and are varying with time. This varying workload within the industry is anticipated to diversify even further over the forecast period as organizations are focusing on expanding the use of HCI systems.

Small organizations prefer improving operational efficiency for the Remote Office/Branch Office (ROBO) IT service and also increasing the use of server virtualization. On the other hand, large enterprises are improving operational efficiency equally with improving backup and disaster recoveries. They also deploy private cloud infrastructure and cloud infrastructure service.HCI systems play a major role in achieving the required scenarios as they are powerful, rich in feature, and simple to operate with a low setup time in comparison to the traditional architectures. These benefits of hyper-converged infrastructure systems are anticipated to drive the demand across large, small, and medium enterprises over the forecast period. Also, the software-centric approach of the HCI systems enables them to meet the current and future business requirements without making any alteration to the existing infrastructure. This paves a way for increased level of adoption across a wide range of industries such as education, banking and finance, healthcare, and others. The cloud computing application segment in hyper-converged infrastructure is also gaining traction and is expected to have a positive impact on the market revenue.

Access Research Report of Hyper-converged Infrastructure Market @ www.grandviewresearch.com/industry-analysis/hyper-converged-infrastructure-hci-market

Further key findings from the report suggest:

·       Virtualization is becoming popular among cost-sensitive customers and large & medium enterprises. The increasingadoption of virtual desktop infrastructure (VDI) on hyper-converged systems leads to the eradication of traditional complex and fragmented infrastructure management in the traditional three-tier based architecture, which is expected to drive the HCI virtualization application in the near future.The cloud-based solution offers benefits such as economies of scale, disaster recovery, effective monitoring of projects, and reduced technology infrastructure cost, which are also expected to foster the growth over the forecast period.

·       Hyper-converged infrastructure is popular in the IT & telecom, financial services, and healthcare & life sciences segments. HCIsystems are also being adopted by the government sector and media & entertainment division. IT & telecom and financial services are the major application segments and together held a market share of over 50% in 2015.

·       EMC Corporation (U.S.), Hewlett-Packard (U.S.), Dell Inc. (U.S.), Atlantis Computing, Inc. (U.S.), Cisco Systems, Inc. (U.S.), Fujitsu Ltd. (U.S.), Hitachi Data Systems (U.S.), NetApp, Inc. (U.S.), Nimboxx, Inc. (U.S.), Nutanix, Inc. (U.S.), Pivot3 (U.S.), Scale Computing, Inc. (U.S.), SimpliVity Corporation (U.S.), and VMware, Inc. (U.S.), among others are some of the major industry players in the hyper-converged infrastructure market

Grand View Research has segmented the hyper-converged infrastructure market on the basis of application, end-use, and region:

Hyper-Converged Infrastructure Application Outlook (Revenue, USD Million, 2013 - 2024)

·         Virtualization

·         Cloud Computing

·         Data Center Consolidation

·         Data Protection

·         Others

Hyper-Converged Infrastructure End-Use Outlook (Revenue, USD Million, 2013 - 2024)

·         IT & Telecom

·         Financial Services

·         Healthcare & Life Sciences

·         Government

·         Media & Entertainment

·         Others

Hyper-Converged Infrastructure Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         South America

·         MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Insomnia Therapeutics Market Detailed Analysis And Future Assumptions For 2025

The Report Insomnia Therapeutics Market Analysis By Treatment Type [Devices, Drugs (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists)], By Sales Channel, And Segment Forecasts, 2018 – 2025

The global insomnia therapeutics market is expected to reach USD 3.45 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by the presence of patented molecules, potential clinical pipeline candidates, rising stress level, and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia & awareness about this condition and availability of safer drugs are anticipated to fuel revenue growth.

Insomnia is estimated to affect approximately 35% of the global population. Different patterns of the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings & awakening too early with trouble sleeping again. Long-term insomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this condition may lead to severe depression and nervous breakdown of the patient.

Factors influencing insomnia therapeutics market growth include rising stress level, presence of patented molecules in the market, potential drugs in clinical pipeline, introduction of technologically advanced medical devices, and growing geriatric population. Growing awareness about the impact of sleep deprivation on everyday life is anticipated to increase adoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.

Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market. Launch of Eisai’s Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According to United Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.

Access Research Report of Insomnia Therapeutics Market @ www.grandviewresearch.com/industry-analysis/insomnia-therapeutics-market

Further Key Findings From the Report Suggest:

·       North America held majority of the share in 2016 due to increase inawareness about diseases, growing geriatricpopulation, and high adoption of therapeutics for treatment.

·       The U.S. dominated North America owing to the presence of largest sleep-deprived population and use of patented drugs for treatment.

·       Japan is the second largest market after the U.S. Asia Pacific is expected to be the fastest growingmarket due to the presence ofemerging economies like China & India and launch of new drugs.

·       Some of the key players are Takeda Pharmaceutical Co. Ltd.; Vanda Pharmaceuticals; Merck & Co, Inc.;Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N. V.; Sumitomo Dainippon Pharma Co., Ltd.; Sanofi; Paratek Pharmaceuticals;and Ebb Therapeutics.

Grand View Research has segmented the insomnia therapeutics market on the basis of treatment type, sales channel, and region:

Insomnia Therapeutics Market Treatment Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Drugs

o    Benzodiazepines

o    Nonbenzodiazepines

o    Antidepressants

o    Orexin antagonist

o    Melatonin antagonist

o    Others

·         Devices

Insomnia Therapeutics Market Sales Channel Outlook (Revenue, USD Million, 2014 - 2025)

·         Prescription

·         Over-the-Counter(OTC)

Insomnia Therapeutics Market Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

o    Mexico

·         Middle East & Africa

o    South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biophotonics Market To Reap Over USD 91.31 Billion In Revenues By End Of 2024

The global biophotonics market was valued at USD 34.29 billion in 2015, which is estimated to reach USD 91.31 billion by 2024, according to a new report by Grand View Research, Inc. The developments in optical technologies, increasing investigations by researchers, and mounting demand for early diagnosis are anticipated to drive the market growth over the forecast period. Biophotonics, being an evolving area of scientific research, has several applications due its ability to harnesses light for comprehending the functioning of cells and tissue in living organisms. This further aids in the better diagnosis of health problems.

Biophotonics market is projected to witness a high growth during the forecast period, owing to its application in optical techniques while simultaneously preserving the integrity of the biological cells under surveillance. New laser microscopes are being developed which permit measurements of distinct molecules and tissues at exceptional resolutions.

Biophotonics also finds applications in numerous procedures including new laser microscopes, which allow exceptional specifications of molecules & single tissues, optical coherence tomography that assists in the minute imaging of biomaterials, and novel light-activated chemicals utilized for welding tissues through surgical procedures.

Considering the enormous application areas, it is becoming perplexing for the key market players to commercialize this technology. However, the market is confronted with a slow commercialization rate due to the low acceptance from end-users, price sensitivity, and concerns pertaining to authenticity, quality, and reliability of the products.

Access Research Report of Biophotonics Market@ http://www.grandviewresearch.com/industry-analysis/biophotonics-market

Further key findings from the report suggest:

·       The non-medical end-use segment is expected to emerge as the fastest-growing segment over the forecast period. The snowballing demand in the non-medical applications is predicted to offer several growth avenues over the next few years. The usage of biophotonics to examine tissues at macro and micro levels and diagnose diseases effectively is expected to be a key reason for its surging end-use applications.

·       The light therapy segment is projected to grow at a CAGR of 14.88% over the forecast period. It accounted for 3.6% of the total market revenue in 2014. This is followed by the surface imaging segment, which is expected to exhibit a high market growth. In addition to this, the market is expected to observe growth with increasing adoption of this technology across various industries, such as biotechnology, therapeutics, agriculture, diagnostics, and life sciences R&D. Other impact rendering applications include environmental monitoring, food analysis, dosimetry, dentistry, and medical imaging utilizing endoscopy and Raman spectroscopy.

·       The Asia Pacific biophotonics market is expected to grow at a CAGR exceeding 13% over the next few years. Due to the augmented investment in R&D activities, coupled with the increasing prevalence of cancer, the market is expected to witness a substantial growth. The increasing healthcare expenditure and rising government initiatives are expected to fuel the demand for the regional market.

·       The prominent industry participants include IPG Photonics Corp., Idex Corp., Toshiba, Procter & Gamble, Horiba, Precision Photonics Corp. (PPC), Roche, GE, Philips, and Danone. The market is projected to exhibit an aggressive competition in the arena of technological development, leading to the application of biophotonic devices in households.

Grand View Research has segmented the global biophotonics market on the basis of end-use, application, and region.

Biophotonics End-Use Outlook (Revenue, USD Billion; 2013 - 2024)

·         Tests and components

·         Medical therapeutics

·         Medical diagnostics

·         Non-medical application

Biophotonics Application Outlook (Revenue, USD Billion; 2013 - 2024)

·         See-Through Imaging

·         Microscopy

·         Inside Imaging

·         Spectro Molecular

·         Other Analytics Sensing

·         Light Therapy

·         Surface Imaging

·         Biosensors

Biophotonics Regional Outlook (Revenue, USD Billion; 2013 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Photonic Integrated Circuit Market Size, Share, Trends, Analysis And Growth Forecast To 2024

The photonic IC market is expected to reach USD 3.54 billion by 2024 according to a new report by Grand View Research, Inc. Photonic IC is an integrated circuit that uses optical wavelength as an information signal and provides multiple integrated photonic functions. Photonic IC, as such, is similar to an electronic IC and can be a viable replacement for it as well as for the copper-based wired transmission. Photonic IC forms an integral part of lasers, optical amplifiers, modulators, and MUX/DEMUX components, which are extensively used in the optical signal processing, optical communication, biophotonics, and sensing applications. The growing demand for sensing and optical devices are expected to fuel the growth of the photonic IC market.

There is an increasing need for cost effective, power efficient, and compact PICs which would further propel the photonic IC market over the forecast period across the mobile broadband Internet access, high-performance computing, datacenter, and enterprise networking, along with metro and long haul data communications, among many others. The increasing adoption of the high-level integrated PICs and application-specific PICs would boost the photonic IC market to strive for greater functionality and new product development across a number of verticals.

The photonic IC market is anticipated to grow substantially due to the continuous technological advancements and the evolving end-user demands. The laser, optical amplifier, and MUX/DEMUX component segments possess enormous growing opportunities, owing to the ability of photonic ICs to incorporate new optical functionalities that can be embedded on a single chip to achieve high efficiency and compactness.

The increasing demand for the optical communication and sensing applications is driving the growth of photonic ICs around the globe with an efficient management of datacenters and long haul networks providing a thriving market for them. Moreover, with the advancements in quantum computing, the adoption of photonic ICs are increasing as they allow multitasking that quantum computing readily requires. Also, the growing adoption of the biophotonic application in medical devices also holds considerable growth opportunities for the photonic ICs market. On the other hand, the high bandwidth and optimum performance requirements of the telecommunication industry, data storage, cloud service providers, and large business enterprises are expected to boost the optical communication and signal processing segments. This market will create many new opportunities culminating in an increased adoption of photonic ICs over the forecasted period.

Access Research Report of Photonic Integrated Circuit Market @ http://www.grandviewresearch.com/industry-analysis/photonic-integrated-circuit-ic-market

Further key findings from the report suggest:

·       There is a growing need for higher bandwidth and greater transmission speeds across the Information and Technology (IT) industry. Photonic ICs can be incorporated into the existing products to fulfill this demand in diverse industry verticals to transmit, receive, and switch high-speed digital signals in communication networks. Progressive research and developments are being made towards the low-cost, high-performance optics to help lower the cost of the high-speed Internet access and boost the efficiency of the telecommunication networks

·       The growing shift towards quantum computing and machine learning, among others, requires enormous parallel computing capabilities. The optical quantum computers can perform much faster than the traditional computers in terms of multitasking, higher level of integration, and efficiency while consuming lower power. This will open new avenues for photonic IC-based computing services across a wide range of verticals.

·       Broadcom Limited (U.S.), Viavi Solutions, Inc. (U.S.), and NeoPhotonics Corporation (U.S.) are some of the major industry players in this domain. Other key vendors include Oclaro, Inc., Kaiam Corp, Luxtera Inc., Infinera Corp., Finisar Corporation, Ciena Corporation, and Emcore Corporation, among others.

Grand View Research has segmented the global photonic integrated circuit (IC) market on the basis of product, application and region:

Photonic IC Market Component Outlook (Revenue, USD Million, 2014 - 2024)

·         Lasers

·         MUX/DEMUX

·         Optical Amplifiers

·         Modulators

·         Attenuators

·         Detectors

Photonic IC Market Raw Material Outlook (Revenue, USD Million, 2014 - 2024)

·         Indium Phosphide (InP)

·         Gallium Arsenide (GaAs)

·         Lithium Niobate (LiNbO3)

·         Silicon

·         Silica-on-Silicon

Photonic IC Market Integration Outlook (Revenue, USD Million, 2014 - 2024)

·         Monolithic Integration

·         Hybrid Integration

·         Module Integration

Photonic IC Market Application Outlook (Revenue, USD Million, 2014 - 2024)

·         Optical Communication

·         Sensing

·         Biophotonics

·         Optical Signal Processing

Photonic IC Market Regional Outlook (Revenue, USD Million, 2014 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.